Mirati Therapeutics (MRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | MRTX | RARE | CRSP | ||
| Company | Mirati Therapeutics | Ultragenyx Pharmaceu | Crispr Therapeutics Ag | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 58.86 | 46.02 | 47.21 | ||
| High | 58.99 | 47.14 | 47.21 | ||
| Low | 58.54 | 45.90 | 45.51 | ||
| Last | 58.70 | 46.02 | 46.29 | ||
| Change | -0.10 | -0.38 | -0.97 | ||
| % Change | -0.17% | -0.82% | -2.05% | ||
| Volume | 20,994,400 | 525,600 | 2,094,500 | ||
| 20-Day Average Volume | 2,385,220 | 978,345 | 1,903,190 | ||
| Previous Close | 58.80 | 46.40 | 47.26 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 58.94 | 49.45 | 49.18 | ||
| 20-Day Raw Stochastic | 17.39% | 24.11% | 5.75% | ||
| 20-Day Relative Strength | 61.06% | 36.18% | 44.77% | ||
| Weighted Alpha | -3.70 | +8.75 | -34.37 | ||
| Today's Opinion | 88% Buy | 24% Sell | 80% Sell | ||
| Previous Opinion | 88% Buy | 24% Sell | 80% Sell | ||
| Last Month's Opinion | 100% Buy | 48% Buy | 88% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -0.98% since 01/12/24 | -3.40% since 11/14/24 | -1.20% since 11/14/24 | ||
| Low | 58.54 on 01/22/24 | 43.04 on 11/18/24 | 45.51 on 11/21/24 | ||
| High | 59.27 on 01/16/24 | 48.11 on 11/15/24 | 48.44 on 11/15/24 | ||
| 1-Month | |||||
| %Chg | -0.41% since 12/22/23 | -15.50% since 10/21/24 | -4.58% since 10/21/24 | ||
| Low | 58.54 on 01/22/24 | 43.04 on 11/18/24 | 45.44 on 10/23/24 | ||
| High | 59.46 on 01/12/24 | 56.38 on 10/23/24 | 59.07 on 11/11/24 | ||
| 3-Month | |||||
| %Chg | +5.42% since 10/20/23 | -19.33% since 08/21/24 | -7.40% since 08/21/24 | ||
| Low | 55.14 on 10/27/23 | 43.04 on 11/18/24 | 43.42 on 09/06/24 | ||
| High | 59.46 on 01/12/24 | 60.37 on 09/16/24 | 59.07 on 11/11/24 | ||
| 6-Month | |||||
| %Chg | +87.48% since 07/21/23 | +13.41% since 05/21/24 | -15.47% since 05/21/24 | ||
| Low | 27.30 on 08/08/23 | 37.02 on 06/18/24 | 43.42 on 09/06/24 | ||
| High | 64.41 on 10/06/23 | 60.37 on 09/16/24 | 67.88 on 06/13/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 4,117,688 | 4,284,762 | 4,033,782 | ||
| Shares Outstanding, K | 70,148 | 92,344 | 85,353 | ||
| Annual Sales | 12,440,000 | 434,250,000 | 371,210,000 | ||
| Annual Net Income | -740,870,000 | -606,640,000 | -153,610,000 | ||
| Last Quarter Sales | 16,400,000 | 139,490,000 | 600,000 | ||
| Last Quarter Net Income | -161,900,000 | -133,520,000 | -85,940,000 | ||
| 60-Month Beta | 0.77 | 0.58 | 1.67 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -2.49 on 11/06/23 | -1.40 on 11/05/24 | -1.01 on 11/05/24 | ||
| Latest Earnings Date | 02/27/24 | 11/05/24 | 11/04/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||